Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Healthcare Biotechnology Medical Instruments & Supplies
Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis... see more

Recent & Breaking News (TSX:EDT)

Spectral Medical (TSX:EDT) reports success of Tigris clinical trial

Jonathon Brown July 20, 2022

Spectral Medical Provides Update on Tigris Clinical Trial

GlobeNewswire July 20, 2022

Spectral Medical Highlights From Vicenza Course 2022

GlobeNewswire July 14, 2022

Spectral Medical to Participate at the Benzinga All Access event on July 15, 2022

GlobeNewswire July 13, 2022

Spectral Medical's (TSX:EDT) Toraymyxin receives Breakthrough Device Designation

John Ballem  July 11, 2022

US FDA Grants Spectral Medical Breakthrough Device Designation for Toraymyxin(TM) ("PMX") for the Treatment of Endotoxemic Septic Shock

GlobeNewswire July 11, 2022

Spectral Medical Inc. Announces Results of Annual and Special Meeting of Shareholders

GlobeNewswire June 21, 2022

Spectral and Dialco Announce Dr. John Kellum to be Featured as Keynote Lecturer at the 40th Vicenza Course on AKI and CRRT 2022

GlobeNewswire June 14, 2022

Spectral Medical (TSX:EDT) announces adoption of SAMI device

Shoran Devi June 13, 2022

Spectral Medical Announces Adoption of SAMI Device by the Largest Inpatient Dialysis Provider in South Florida

GlobeNewswire June 13, 2022

Spectral Medical Announces Appointment of Leading Industry Executive Sam Amory as Dialco President

GlobeNewswire May 16, 2022

Spectral to Present at Microcap Rodeo's Spring into Action Best Ideas Virtual Conference on May 16th

Accesswire May 13, 2022

Spectral Announces First Quarter Results and Provides Corporate Update

GlobeNewswire May 13, 2022

Spectral to Present at Investor Summit Group's Q2 In-person Conference on May 3rd in NYC

Newsfile April 27, 2022

Spectral Announces Fourth Quarter and Fiscal 2021 Results and Corporate Update

GlobeNewswire March 24, 2022

Spectral Medical Announces Appointment of Blair McInnis as CFO

GlobeNewswire March 21, 2022

Dialco Medical Announces Formation of Medical Advisory Board to Support the Continued Development of DIMI Device

GlobeNewswire March 16, 2022

Spectral Medical CMO Dr. John Kellum to Present at the 27th International AKI & CRRT Conference on March 7-10, 2022

GlobeNewswire March 4, 2022

Spectral Medical (TSX:EDT) progresses on treatment trial against septic shock

Caroline Egan  February 11, 2022

Spectral Medical Reports Progress on Tigris Clinical Trial

GlobeNewswire February 11, 2022